Global Microbiome Therapeutics Competitive Landscape Professional Research Report 2025
Description
Global Microbiome Therapeutics Competitive Landscape Professional Research Report 2025
Research Summary
Microbiome therapeutics, also known as microbiota-based therapies, are treatments or interventions that aim to modify the composition or function of the microbiome to improve health outcomes. The microbiome refers to the collection of microorganisms (such as bacteria, viruses, fungi, and archaea) that inhabit the human body, particularly the gut, and play important roles in digestion, immunity, metabolism, and overall well-being. Microbiome therapeutics can include a range of approaches, such as probiotics (live beneficial microorganisms), prebiotics (substances that promote the growth of beneficial microorganisms), postbiotics (metabolites or byproducts of microbial activity), fecal microbiota transplantation (transferring fecal material containing a healthy microbiome into a recipient.
According to DIResearch's in-depth investigation and research, the global Microbiome Therapeutics market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Microbiome Therapeutics include Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon, PureTech, Synlogic, Enterome BioScience, 4D Pharma, Second Genome, AOBiome, C3 Jian, Rebiotix, MicroBiome Therapeutics, Metabiomics, Ritter Pharmaceuticals, Symberix, Azitra, OpenBiome, Osel, Symbiotix Biotherapies, Metabogen etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Microbiome Therapeutics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Microbiome Therapeutics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Microbiome Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Microbiome Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Microbiome Therapeutics Include:
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
C3 Jian
Rebiotix
MicroBiome Therapeutics
Metabiomics
Ritter Pharmaceuticals
Symberix
Azitra
OpenBiome
Osel
Symbiotix Biotherapies
Metabogen
Microbiome Therapeutics Product Segment Include:
Upper GIT
Lower GIT
Microbiome Therapeutics Product Application Include:
C. difficile Infection (CDI)
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-oncology
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Microbiome Therapeutics Industry PESTEL Analysis
Chapter 3: Global Microbiome Therapeutics Industry Porter’s Five Forces Analysis
Chapter 4: Global Microbiome Therapeutics Major Regional Market Size and Forecast Analysis
Chapter 5: Global Microbiome Therapeutics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Microbiome Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Microbiome Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Microbiome Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Microbiome Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Microbiome Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Microbiome Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Microbiome Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Microbiome Therapeutics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Microbiome Therapeutics Product by Type
- 1.2.1 Upper GIT
- 1.2.2 Lower GIT
- 1.3 Microbiome Therapeutics Product by Application
- 1.3.1 C. difficile Infection (CDI)
- 1.3.2 Inflammatory Bowel Disease (IBD)
- 1.3.3 Orphan Drug
- 1.3.4 Immuno-oncology
- 1.3.5 Others
- 1.4 Global Microbiome Therapeutics Market Size Analysis (2020-2032)
- 1.5 Microbiome Therapeutics Market Development Status and Trends
- 1.5.1 Microbiome Therapeutics Industry Development Status Analysis
- 1.5.2 Microbiome Therapeutics Industry Development Trends Analysis
- 2 Microbiome Therapeutics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Microbiome Therapeutics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Microbiome Therapeutics Market Analysis by Regions
- 4.1 Microbiome Therapeutics Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Microbiome Therapeutics Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Microbiome Therapeutics Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Microbiome Therapeutics Revenue Forecast by Region (2026-2032)
- 5 Global Microbiome Therapeutics Market Size by Type and Application
- 5.1 Global Microbiome Therapeutics Market Size by Type (2020-2032)
- 5.2 Global Microbiome Therapeutics Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Microbiome Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Microbiome Therapeutics Market Size by Type
- 6.4 North America Microbiome Therapeutics Market Size by Application
- 6.5 North America Microbiome Therapeutics Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Microbiome Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Microbiome Therapeutics Market Size by Type
- 7.4 Europe Microbiome Therapeutics Market Size by Application
- 7.5 Europe Microbiome Therapeutics Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Microbiome Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Microbiome Therapeutics Market Size by Type
- 8.4 China Microbiome Therapeutics Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Microbiome Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Microbiome Therapeutics Market Size by Type
- 9.4 APAC (excl. China) Microbiome Therapeutics Market Size by Application
- 9.5 APAC (excl. China) Microbiome Therapeutics Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Microbiome Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Microbiome Therapeutics Market Size by Type
- 10.4 Latin America Microbiome Therapeutics Market Size by Application
- 10.5 Latin America Microbiome Therapeutics Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Microbiome Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Microbiome Therapeutics Market Size by Type
- 11.4 Middle East & Africa Microbiome Therapeutics Market Size by Application
- 11.5 Middle East & Africa Microbiome Therapeutics Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Microbiome Therapeutics Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Microbiome Therapeutics Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Microbiome Therapeutics Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Seres Therapeutics
- 13.1.1 Seres Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Seres Therapeutics Microbiome Therapeutics Product Portfolio
- 13.1.3 Seres Therapeutics Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Assembly Biosciences
- 13.2.1 Assembly Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Assembly Biosciences Microbiome Therapeutics Product Portfolio
- 13.2.3 Assembly Biosciences Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Synthetic Biologics
- 13.3.1 Synthetic Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Synthetic Biologics Microbiome Therapeutics Product Portfolio
- 13.3.3 Synthetic Biologics Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Interxon
- 13.4.1 Interxon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Interxon Microbiome Therapeutics Product Portfolio
- 13.4.3 Interxon Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 PureTech
- 13.5.1 PureTech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 PureTech Microbiome Therapeutics Product Portfolio
- 13.5.3 PureTech Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Synlogic
- 13.6.1 Synlogic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Synlogic Microbiome Therapeutics Product Portfolio
- 13.6.3 Synlogic Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Enterome BioScience
- 13.7.1 Enterome BioScience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Enterome BioScience Microbiome Therapeutics Product Portfolio
- 13.7.3 Enterome BioScience Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 4D Pharma
- 13.8.1 4D Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 4D Pharma Microbiome Therapeutics Product Portfolio
- 13.8.3 4D Pharma Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Second Genome
- 13.9.1 Second Genome Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Second Genome Microbiome Therapeutics Product Portfolio
- 13.9.3 Second Genome Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 AOBiome
- 13.10.1 AOBiome Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 AOBiome Microbiome Therapeutics Product Portfolio
- 13.10.3 AOBiome Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 C3 Jian
- 13.11.1 C3 Jian Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 C3 Jian Microbiome Therapeutics Product Portfolio
- 13.11.3 C3 Jian Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Rebiotix
- 13.12.1 Rebiotix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Rebiotix Microbiome Therapeutics Product Portfolio
- 13.12.3 Rebiotix Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 MicroBiome Therapeutics
- 13.13.1 MicroBiome Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 MicroBiome Therapeutics Microbiome Therapeutics Product Portfolio
- 13.13.3 MicroBiome Therapeutics Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 Metabiomics
- 13.14.1 Metabiomics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Metabiomics Microbiome Therapeutics Product Portfolio
- 13.14.3 Metabiomics Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.15 Ritter Pharmaceuticals
- 13.15.1 Ritter Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Ritter Pharmaceuticals Microbiome Therapeutics Product Portfolio
- 13.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.16 Symberix
- 13.16.1 Symberix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 Symberix Microbiome Therapeutics Product Portfolio
- 13.16.3 Symberix Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.17 Azitra
- 13.17.1 Azitra Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.17.2 Azitra Microbiome Therapeutics Product Portfolio
- 13.17.3 Azitra Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.18 OpenBiome
- 13.18.1 OpenBiome Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.18.2 OpenBiome Microbiome Therapeutics Product Portfolio
- 13.18.3 OpenBiome Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.19 Osel
- 13.19.1 Osel Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.19.2 Osel Microbiome Therapeutics Product Portfolio
- 13.19.3 Osel Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.20 Symbiotix Biotherapies
- 13.20.1 Symbiotix Biotherapies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.20.2 Symbiotix Biotherapies Microbiome Therapeutics Product Portfolio
- 13.20.3 Symbiotix Biotherapies Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.21 Metabogen
- 13.21.1 Metabogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.21.2 Metabogen Microbiome Therapeutics Product Portfolio
- 13.21.3 Metabogen Microbiome Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Microbiome Therapeutics Industry Chain Analysis
- 14.2 Microbiome Therapeutics Industry Raw Material and Suppliers Analysis
- 14.2.1 Microbiome Therapeutics Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Microbiome Therapeutics Typical Downstream Customers
- 14.4 Microbiome Therapeutics Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
